Serum Institute Of India - REPOITIN (PFS) - Recombinant Human Erythropoietin (rHuEPO) Injection

Repoitin PFS

Recombinant Human Erythropoietin (rHuEPO) Injection

INDICATION

Treatment of Anaemia in Chronic Kidney Failure /ESKD patients Treatment of Chemotherapy induced Anaemia in Cancer patients Treatment of Anaemia in Zidovudine-treated HIV-infected patients

ROUTE OF ADMINISTRATION

I.V. and S.C. Injection.

DOSAGE

As directed by physician

COMPOSITION

Perioperative Surgery Patients needing Allogenic Blood Transfusion Adult Surgery Patients in an Autologous Pre-Donation Programme

PRESENTATION:

The product is available in single use pre-filled syringe (PFS) and vials containing Epoitin Alfa at different strengths and fill volumes

2000 IU/ 0.5 ml pre-filled syringe
3000 IU/ 0.3 ml pre-filled syringe
4000 IU/ 0.4 ml pre-filled syringe
5000 IU/ 0.5 ml pre-filled syringe
6000 IU/ 0.6 ml pre-filled syringe
10000 IU/ 1.0 ml pre-filled syringe

PRODUCTS SUPPLIED IN INDIA

Repoitin PFS

INDICATION

ROUTE OF ADMINISTRATION

DOSAGE

COMPOSITION

PRESENTATION:

Home

About Us

Products

R & D

HEALTH FAQ

MILESTONES

NEWS

CONTACT Us

CAREERS

POONAWALLA GROUP